Kiortsis D - Search Results

1

Consequences of the discontinuation of antihypertensive treatment in successfully treated patients.

Charalabopoulos K, Charalabopoulos A, Papalimneou V, Kiortsis D, Dimicco P, Kostoula OK, Karachalios GN. Charalabopoulos K, et al. Among authors: kiortsis d. Int J Clin Pract. 2005 Jun;59(6):704-8. doi: 10.1111/j.1742-1241.2005.00523.x. Int J Clin Pract. 2005. PMID: 15924599 Review.

2

Effects of cigarette smoking on the antioxidant defence in young healthy male volunteers.

Charalabopoulos K, Assimakopoulos D, Karkabounas S, Danielidis V, Kiortsis D, Evangelou A. Charalabopoulos K, et al. Among authors: kiortsis d. Int J Clin Pract. 2005 Jan;59(1):25-30. doi: 10.1111/j.1742-1241.2004.00340.x. Int J Clin Pract. 2005. PMID: 15707460

3

Withdrawal syndrome following cessation of antihypertensive drug therapy.

Karachalios GN, Charalabopoulos A, Papalimneou V, Kiortsis D, Dimicco P, Kostoula OK, Charalabopoulos K. Karachalios GN, et al. Among authors: kiortsis d. Int J Clin Pract. 2005 May;59(5):562-70. doi: 10.1111/j.1368-5031.2005.00520.x. Int J Clin Pract. 2005. PMID: 15857353 Review.

4

Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidence.

Tsouli SG, Liberopoulos EN, Kiortsis DN, Mikhailidis DP, Elisaf MS. Tsouli SG, et al. J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):1-15. doi: 10.1177/107424840601100101. J Cardiovasc Pharmacol Ther. 2006. PMID: 16703216 Review.

5

Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis.

Derdemezis CS, Filippatos TD, Voulgari PV, Tselepis AD, Drosos AA, Kiortsis DN. Derdemezis CS, et al. Among authors: kiortsis dn. Fundam Clin Pharmacol. 2009 Oct;23(5):595-600. doi: 10.1111/j.1472-8206.2009.00717.x. Epub 2009 Jun 25. Fundam Clin Pharmacol. 2009. PMID: 19563510 Clinical Trial.

6

Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.

Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA. Kiortsis DN, et al. J Rheumatol. 2006 May;33(5):921-3. Epub 2006 Mar 15. J Rheumatol. 2006. PMID: 16541480 Clinical Trial.

7

A review of the metabolic effects of controlled-release Phentermine/Topiramate.

Kiortsis DN. Kiortsis DN. Hormones (Athens). 2013 Oct-Dec;12(4):507-16. doi: 10.14310/horm.2002.1438. Hormones (Athens). 2013. PMID: 24457398 Free article. Review.

8

The Current Role of Liraglutide in the Pharmacotherapy of Obesity.

Christou GA, Katsiki N, Kiortsis DN. Christou GA, et al. Curr Vasc Pharmacol. 2016;14(2):201-7. doi: 10.2174/1570161113666150615111951. Curr Vasc Pharmacol. 2016. PMID: 26074046 Review.

9

The efficacy and safety of the naltrexone/bupropion combination for the treatment of obesity: an update.

Christou GA, Kiortsis DN. Christou GA, et al. Hormones (Athens). 2015 Jul-Sep;14(3):370-5. doi: 10.14310/horm.2002.1600. Hormones (Athens). 2015. PMID: 26188223 Free article. Review.

10

Lipid-lowering drugs and serum liver enzymes: the effects of body weight and baseline enzyme levels.

Kiortsis DN, Nikas S, Hatzidimou K, Tsianos E, Elisaf MS. Kiortsis DN, et al. Fundam Clin Pharmacol. 2003 Aug;17(4):491-4. doi: 10.1046/j.1472-8206.2003.00176.x. Fundam Clin Pharmacol. 2003. PMID: 12914553 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page